A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
Clinical trial NCT05654454 · RECRUITING
Trial details
- NCT number
- NCT05654454
- Sponsor
- Mabscale, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2026-12-01
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.